Clinical Trial Details
EORTC-55005
Back to Clinical Trials Database
A randomized phase III study comparing Gemcitabine plus Carboplatin versus Carboplatin monotherapy in patients with advanced eepithelial ovarian carcinoma who failed first-line platinum based therapy Intergroup AGO-EORTC-NCIC CTG trial (EORTC 55005)
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 03-Apr-2001 Date Step1 close: 30-Apr-2002 Date Step2 close: 30-Apr-2002 |
| Data management at EORTC | No |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 250 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
